Form 4: Clene Inc. Director Shalom Jacobovitz Acquires 30,000 Stock Options

Director Shalom Jacobovitz reports the acquisition of 30,000 stock options in Clene Inc. on May 29, 2024.

Summary

• On May 29, 2024, Shalom Jacobovitz, a director of Clene Inc., acquired 30,000 stock options.
• These options were granted under the Clene Inc. Amended 2020 Stock Plan.
• The exercise price for the options is $0.37 per share.
• The options vest in 12 equal monthly installments starting June 29, 2024, and will be fully vested by May 2025.
• The options expire on May 28, 2034.

Sentiment

Score: 6

Explanation: The document is a neutral report of stock option grants, which is a common practice. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

NA

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize executives and directors.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates